The Impact of the Ontario Fertility Program on Duplicate Fertility Consultations.


Journal

Healthcare policy = Politiques de sante
ISSN: 1715-6580
Titre abrégé: Healthc Policy
Pays: Canada
ID NLM: 101280107

Informations de publication

Date de publication:
05 2019
Historique:
entrez: 20 7 2019
pubmed: 20 7 2019
medline: 14 7 2020
Statut: ppublish

Résumé

The Ontario Fertility Program (OFP) funds 5,000 annual in vitro fertilization (IVF) cycles. We hypothesized that after introduction of the OFP, there would be an increase in duplicate infertility consultations by patients attempting to increase chances at obtaining publicly funded IVF through enlisting at multiple fertility clinics. This retrospective observational study included women eligible for healthcare services in Ontario from 2014 to 2016 and compared infertility consultations pre- and post-initiation of the OFP. Post-OFP, the average number of consultations per patient and the proportion of patients with more than one consult increased (1.04 vs. 1.05, p = 0.015 and 3.8% vs. 4.2%, p = 0.027, respectively). Total consultations for infertility increased from 24,565 to 27,714 post-OFP. The OFP had the largest impact in the Greater Toronto Area (GTA). The OFP resulted in a statistically significant increase in duplicate consultations, although unlikely to be of clinical relevance. The disproportionate impact seen in the GTA highlights the inequitable access to fertility care in Ontario.

Identifiants

pubmed: 31322115
pii: hcpol.2019.25855
doi: 10.12927/hcpol.2019.25855
pmc: PMC7008682
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

66-77

Informations de copyright

Copyright © 2019 Longwoods Publishing.

Références

Fertil Steril. 2005 Jul;84(1):221-3
pubmed: 16009188
Fertil Steril. 2009 Nov;92(5):1520-4
pubmed: 19828144
N Engl J Med. 2002 Aug 29;347(9):661-6
pubmed: 12200554
J Obstet Gynaecol Can. 2017 Mar;39(3):138-144
pubmed: 28343554
Can Public Policy. 1995 Sep;21(3):379-81
pubmed: 11660295
N Engl J Med. 2013 May 16;368(20):1948-9
pubmed: 23675672
CMAJ Open. 2019 Jun 11;7(2):E385-E390
pubmed: 31186285

Auteurs

Angela Assal (A)

Endocrinologist, Division of Endocrinology and Metabolism, Sunnybrook Health Sciences Centre, Toronto, ON.

Claire Ann Jones (CA)

GREI Specialist, Department of Obstetrics and Gynaecology, Mount Sinai Fertility, Sinai Health System, Toronto, ON.

Tamas Gotz (T)

GREI Specialist, Department of Obstetrics and Gynaecology, Mount Sinai Fertility, Sinai Health System, Toronto, ON.

Baiju R Shah (BR)

Endocrinologist, Division of Endocrinology and Metabolism, Sunnybrook Health Sciences Centre, Institute for Clinical Evaluative Sciences, Toronto, ON.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH